1 / 1

The HMO Research Network – 2008-2009 Portfolio Snapshots

The HMO Research Network – 2008-2009 Portfolio Snapshots. WHO FUNDED HMORN ACTIVITIES 95% of the Network’s research funding came from federal sources. Non-federal sources include foundations and societies, pharmaceutical industry entities, and internal research funded by the health plans.

kaspar
Download Presentation

The HMO Research Network – 2008-2009 Portfolio Snapshots

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The HMO Research Network – 2008-2009 Portfolio Snapshots WHO FUNDED HMORN ACTIVITIES 95% of the Network’s research funding came from federal sources. Non-federal sources include foundations and societies, pharmaceutical industry entities, and internal research funded by the health plans. HMORN PROJECT LEADERSHIP Fifty-two different researchers from within the HMORN led or PI’ed a Network-based project during 2008 - 2009. External partners led or PI’ed 15 HMORN projects (13%) during the same period. HMORN PROJECT PARTICIPATION The total number of sites involved ranged from 2 to 15 per project. On average, 5 sites were involved, with a standard deviation of 3.2. Of the 119 HMORN studies reported, 45 (38%) included non-HMORN partners. A total of 42 different external partners were reported, most of which are University-based. BACKGROUND In September 2010, the HMO Research Network (HMORN) received a 1-year administrative supplement to initiate development of a collaborative population-based laboratory, or “Collaboratory”. This award stems from NIH’s interest in enhancing the nation’s capacity to perform larger and more efficient epidemiological studies, interventions and analyses that collectively enable rapid responses to important questions in healthcare. The supplement is geared toward understanding the HMORN’s organizational structure and capacity in three areas: governance and operations; overall research portfolio and potential gaps in capacity; and data resources. This poster presents preliminary snapshots from the overall research portfolio of the HMORN for 2008-2009. PROJECT TYPE The primary study design was reported for 110 of the projects. Of these, 62% primarily utilized observational methods. LEAD SITES The number of projects led per HMORN site ranged from 0 to 29. Of the 15 U.S. sites, 13 led an HMORN project during 2008 and 2009. HHS FUNDING – A CLOSER LOOK Funding from federal sources is shown below for 2008 and 2009 (approximate). Support for the HMORN’s largest consortia (cancer, cardiovascular health, vaccine safety, mental health, medication safety) is clearly evident – as well as the HMORN’s capacity for healthcare delivery research. METHODS LIMITATIONS Not all projects may have been captured and reported. A greater portion of Cancer Research Network (CRN) projects may be reported. When number of VSD sites was not known, 8 sites were assumed. ACKNOWLEDGEMENTS Special thanks to and Karin Johnson, PhD and Sarah McDonald of GHRI, the entire HMORN Collaboratory team, and the Cancer Research Network supplement U19 CA 079689 – S12.

More Related